Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects

NCT00388609 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

705

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BMS-646256
DRUG: Placebo

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]